[FDMT] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
29-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -101.93%
YoY- -663.86%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 3,633 3,535 2,030 540 2,208 2,208 4,531 -13.70%
PBT -15,153 -13,160 -16,115 -16,675 -8,258 -8,258 -2,183 264.31%
Tax -14 -130 -218 -341 0 0 0 -
NP -15,153 -13,160 -16,115 -16,675 -8,258 -8,258 -2,183 264.31%
Tax Rate - - - - - - - -
Total Cost 18,786 16,695 18,145 17,215 10,466 10,466 6,713 98.70%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -417.09 -372.28 -793.84 -3,087.96 -374.00 -374.00 -48.17 322.22%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.02 -0.89 -1.09 -1.12 -1.61 -1.61 -0.43 77.95%
EPS Diluted -1.02 -0.89 -1.09 -1.12 -1.61 -1.61 -0.43 77.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.